Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating disease using recombinant adeno-associated virus virions administered to muscle

Methods of treating disease using recombinant adeno-associated virus virions administered to muscle

US Patent 6325998 · Granted Dec 4, 2001

Estimated economic value: $3,430,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Apparatus and methods for testing visual function and functional vision at varyi2019
Methods of treating anemia using recombinant adeno-associated virus virions2010
Methods of treating anemia using recombinant adeno-associated virus virions2010
Methods for delivering DNA to muscle cells using recombinant adeno-associated vi2010
Methods for delivering DNA to muscle cells using recombinant adeno-associated vi2010
Methods for delivering DNA to muscle cells using recombinant adeno-associated vi2007
Methods for delivering DNA to muscle cells using recombinant adeno-associated vi2007
Production of recombinant AAV using adenovirus comprising AAV rep/cap genes2006
Induction of immune response to antigens expressed by recombinant adeno-associat2004
Adeno associated virus vectors for the treatment of a cardiomyopathy2003
Adeno associated virus vectors for the treatment of a cardiomyopathy2003
Recombinant adeno-associated virus virions for the treatment of lysosomal disord2003